Sacubitril/valsartan in heart failure: Differing added benefit
(Institute for Quality and Efficiency in Health Care) Due to a subgroup effect, there is an indication of a minor added benefit for patients with diabetes, and an indication of a considerable added benefit for patients without diabetes.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news
More News: Cardiology | Diabetes | Diovan | Endocrinology | Health | Health Management | Heart | Heart Failure | International Medicine & Public Health